-
Currax Pharmaceuticals Acquires North American Rights to ONZETRA Xsail
Post on 9/26/19
-
Dialyze Direct Expands Dialysis Services into Maryland
Post on 9/25/19
-
St. Joseph's Health and Hackensack Meridian Health Announce Clinical and Strategic Partnership
Post on 9/25/19
-
Citius Announces Pricing of $7.0 Million Underwritten Offering Priced At-the-Market
Post on 9/25/19
-
Enhanced Healthcare Partners Announces Closing of New Fund
Post on 9/24/19
-
Provention Bio Reiterates Regulatory Strategy for PRV-031 and Announces Completion of Follow-on Financing
Post on 9/24/19
-
Bioasis Announces Proposed Private Placement
Post on 9/23/19
-
GenScript Partners with Harvard University
Post on 9/23/19
-
Mercer and Xevant Announce Strategic Plan Optimization Solution for Employer-Sponsored Pharmacy Benefit Plans
Post on 9/23/19
-
Cantel Medical Reports Financial Results for its Fourth Quarter Fiscal Year 2019
Post on 9/23/19
-
Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes
Post on 9/23/19
-
Johnson & Johnson: Opportunity Beckons - Know When To Strike
Post on 9/23/19
-
Johnson & Johnson Portfolio: Halftime Report
Post on 9/23/19
-
3 Biotechs With the Biggest Cash Stockpiles
Post on 9/23/19
-
Schizophrenia Clinical Research Receives NIMH Funding to Improve Treatment
Post on 9/22/19
-
Yesse Technologies Awarded $750K SBIR Phase II Grant From The National Science Foundation
Post on 9/22/19
-
Celgene Corp. Names Second Round of Celgene Cancer Care Links Program Grant Recipients
Post on 9/22/19
-
ARS Treatment Centers Announces Two New Office-Based Opioid Treatment Clinics in New Jersey
Post on 9/22/19
-
Johnson & Johnson: Opportunity Beckons - Know When To Strike
Post on 9/20/19
-
Medicrea Reports First Half 2019 Financial Results
Post on 9/19/19
-
New Jersey Urology Partners with Premier Urology Group
Post on 9/18/19
-
PTC Therapeutics Prices Public Offering of Common Stock
Post on 9/18/19
-
The Beekman Group Partners with Twin Boro Physical Therapy
Post on 9/18/19
-
IQVIA Collaborates with Cancer Researchers
Post on 9/18/19
-
PTC Therapeutics Proposes Public Offering of Common Stock
Post on 9/17/19